AmplifAI Health selected for WEF’s MINDS programme

AI in healthcare has been talked about for years. But talk doesn't cut it when lives are on the line. This month at Davos, a new cohort of AI innovators showed the world what real-world impact looks like. Among them is AmplifAI Health, a company using artificial intelligence and thermal imaging to change the way diabetic foot risk is detected and treated. It's not a theory anymore. It's happening on the ground, in partnership with the Ministry of Health of Saudi Arabia and backed by global leaders.

The World Economic Forum's MINDS programme stands for Meaningful, Intelligent, Novel, Deployable Solutions. It's not about flashy prototypes. It's about solutions that are proven, measurable and ready to be scaled.

How does it work?

AmplifAI Health's approach is clever yet practical. Instead of reinventing the wheel, it pairs existing medical imaging with AI that learns what to look for in thermal patterns on a patient's foot. Think of it as giving eyes to the machine that can spot danger before a clinician sees it.

Here's what makes it real and relevant:

• Thermal AI screens for diabetic foot risk using advanced analytics.
• It connects with clinical systems so the results fit into normal hospital workflows.
• Screening capacity jumps without hiring more specialists - a 12-fold increase.
• Treatment cost for complications sees major cuts, up to 80%.

The system isn't just clever. It's clinically validated and regulator-approved, meaning it works in everyday care, not just in a lab. That's huge in health tech, where many promising ideas never cross that chasm.

Why does it matter?

Here's the heart of it. AI isn't worth much until it makes a measurable difference in people's lives. The fact that AmplifAI Health's solution:

• Reduces healthcare costs
• Increases screening capacity
• Helps clinicians catch problems earlier

...means patients can get better care faster and health systems can run smarter. That's not buzzword bingo. That's the result.

Maria Basso of the World Economic Forum said it best: the MINDS programme "spotlights AI solutions that are not only innovative but also grounded in societal needs."

This matters in a broader sense. The global healthcare sector struggles with rising costs and staffing shortages. Tools that boost efficiency and improve outcomes without adding burdens are worth paying attention to. And when they're built with people at the center, they stand a better chance of being trusted and adopted. That's essential if AI is going to be part of the future of health.

The context

The World Economic Forum isn't rolling out ribbons for tech demos. Its MINDS programme pulls from industries around the world to show what scaled AI adoption looks like in action. The recent report on real-world AI adoption shows organizations that have moved beyond pilot stages and are delivering measurable performance gains. It underlines patterns like embedding AI into strategy, boosting human-AI collaboration, and building responsible governance into every step.

For healthcare AI in particular, real-world impact has been slow to come. There are high hopes and big promises, but very few solutions reach the point where clinicians trust them and regulators clear them. AmplifAI Health's acceptance into the MINDS cohort puts it alongside global names and innovators. It signals that healthcare AI can leave the sandbox and shift into real practice.

Dr. Meshari Alwashmi, CEO of AmplifAI Health, captured the moment: "Acceptance into the World Economic Forum's MINDS programme is a meaningful milestone that reflects the real-world value of AI when it is integrated thoughtfully, responsibly, and at scale."

And that's the rub. AI isn't just a tool. It's a new way of thinking about healthcare delivery. With partners from national ministries to global forums aligning behind real outcomes, it looks like we're finally past proof of concept and heading toward proof of impact.